FBFS
ADMA icon

First Business Financial Services’s ADMA Biologics ADMA Stock Holding History

First Business Financial Services’s Portfolio ADMA Stock Details ADMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-20,000
Closed -$343K – 171
2024
Q4 		$343K Buy
+20,000
New +$376K 0.03% 133

Other funds holding ADMA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
PL
Perpetual Ltd Sydney, New South Wales, Australia $7B AUM 19.75% 1-Year Est. Return

First Business Financial Services's ADMA Position: Q1 2025 in Review

First Business Financial Services sold out of ADMA Biologics (ADMA) in Q1 2025, closing a stake of 20,000 shares — an estimated $343K sold.

First Business Financial Services first reported a position in ADMA in Q4 2024 and held it in 1 quarter. The position peaked at $343K in Q4 2024. 347 funds tracked by Wall St. Rank hold ADMA as of Q1 2025.

  • First Business Financial Services reported no remaining ADMA Biologics position as of Q1 2025 after selling out during the quarter.
  • First Business Financial Services sold 20,000 ADMA Biologics shares in Q1 2025, an estimated $343K.
  • First Business Financial Services first reported a position in ADMA Biologics in Q4 2024 and held it in 1 quarter.
  • First Business Financial Services's ADMA Biologics position peaked at $343K in Q4 2024.
  • 347 funds tracked by Wall St. Rank held ADMA Biologics as of Q1 2025.

Based on First Business Financial Services's 13F filing for Q1 2025, filed 2 May 2025.